Page last updated: 2024-09-02
3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dizzyness
3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Dizzyness in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Hartman, NG; Lavigne, GJ; Lobbezoo, F; Montplaisir, JY; Soucy, JP | 1 |
Trials
1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Dizzyness
Article | Year |
---|---|
Effects of the D2 receptor agonist bromocriptine on sleep bruxism: report of two single-patient clinical trials.
Topics: Adult; Benzamides; Bromocriptine; Bruxism; Corpus Striatum; Cross-Over Studies; Dizziness; Dopamine Agonists; Dopamine Antagonists; Double-Blind Method; Electromyography; Female; Humans; Iodine Radioisotopes; Male; Masseter Muscle; Nausea; Patient Dropouts; Placebos; Polysomnography; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine; Sleep; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 1997 |